StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance SRNE stock opened at $0.14 on Thursday. Sorrento Therapeutics has a 1 year low of $0.16 and a 1 year high […]
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ SRNE opened at $0.09 on Tuesday. The company has a quick ratio of 0.79, a current ratio of 0.88 and a […]
Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) and Ginkgo Bioworks (NYSE:DNA – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk. Institutional & Insider Ownership 34.5% of Sorrento Therapeutics […]
StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance NASDAQ SRNE opened at $0.19 on Friday. Sorrento Therapeutics has a 1-year low of $0.16 and a 1-year high of $3.09. The […]
StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Sorrento Therapeutics stock opened at $0.15 on Friday. The company has a debt-to-equity ratio of 0.14, a quick […]